Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Press Releases
Syndax Pharmaceuticals, Inc.  
January 7, 2025

Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 7, 2025 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive

logo salamanca press

Salamanca Press

Local & Social